General Information of the Compound
| Compound ID |
CP0856498
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)-7-fluoroimidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)-2-(methyloxy)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C42H41F3N8O3
|
||||||||||||||||||
| Molecular Weight |
762.837
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(N2CCC(N3CCCCC3)CC2)ccc1Nc1nccc(-c2c(-c3ccc(OC)c(C(=O)Nc4c(F)cccc4F)c3)nc3cc(F)ccn23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C42H41F3N8O3/c1-55-35-12-9-26(23-30(35)41(54)50-39-31(44)7-6-8-32(39)45)38-40(53-22-14-27(43)24-37(53)49-38)34-13-17-46-42(48-34)47-33-11-10-29(25-36(33)56-2)52-20-15-28(16-21-52)51-18-4-3-5-19-51/h6-14,17,22-25,28H,3-5,15-16,18-21H2,1-2H3,(H,50,54)(H,46,47,48)
Show/Hide
|
||||||||||||||||||
| InChIKey |
FDYVCVGOCWYNGV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor